Search

everythinglearnresearchcommunity

for

Search:↓

The treatment is safe and shows promise for metastatic breast cancer.

Most patients experienced mild to moderate skin problems during a trial for a desmoid tumor treatment.

Imatinib can repigment grey hair, while SU11428 can cause temporary hair depigmentation.

DOPE:DOPC liposomes can improve targeted cancer drug delivery, reducing side effects and increasing effectiveness.

A woman's vitiligo improved with tofacitinib treatment, and her skin color remained even after stopping the medication, but there are concerns about cancer risk.

GC10/DOX hydrogel shows promise as an effective thyroid cancer treatment.

Prostaglandins may protect hair follicles during chemotherapy.

Combining either fractional CO2 laser or microneedling with 5-FU is more effective for treating vitiligo.

Chemotherapy caused hair loss with specific patterns, but most patients had hair regrowth after treatment, while some had lasting hair loss.

TICE salvage chemotherapy is effective for treating germ-cell tumors with poor prognosis.

CT-707 is effective and safe for treating certain Chinese lung cancer patients.

Fulvestrant is a well-tolerated new treatment for advanced breast cancer that may delay chemotherapy.

UVA1-light therapy successfully treated a child's skin condition, mycosis fungoides.

Most patients experienced significant but reversible hair loss during treatment.

Botox injections may be a safe and effective way to treat severe, itchy skin disease when other treatments fail.

Combining fractional CO2 laser or microneedling with 5-FU is more effective and safer for treating vitiligo.

Gefitinib and Sasam-Kyeongokgo together significantly reduce cancer growth and improve immune response in mice.

Using tacalcitol ointment with photodynamic therapy may effectively treat follicular mucinosis with scalp hair loss.

Sorafenib can cause delayed skin problems, so patients need careful monitoring.

Patients and oncologists prioritize survival benefits, while payers focus on treatment costs.

Chemotherapy can cause various skin problems, and recognizing them helps improve patient care.

Trodelvy™ helped some patients with advanced breast cancer, but had side effects.

Sintilimab with chemotherapy improves survival and response in advanced lung cancer but increases some side effects.

Early diagnosis and treatment are crucial for managing Folliculotropic Mycosis Fungoides on the scalp.

Combining Western chemotherapy with Traditional Chinese Medicine can reduce side effects and improve immune response in treating bone and soft tissue tumors.

Tofacitinib effectively treated both ulcerative colitis and alopecia areata in two patients.

Chemotherapy often causes hair loss, which is distressing for many, but usually reversible.

CDK4/6 inhibitors may cause hair loss in breast cancer patients.

The new drug delivery system effectively targets lung cancer cells.

A man developed a skin cancer called folliculotropic mycosis fungoides after a kidney transplant.